ARG1 and neoplasm: The ARG1 small molecule inhibitor CB-1158 (Table 1) blocks arginase, attenuates myeloid cell–mediated immune escape and tumor growth, and is beneficial to T-cell proliferation (Steggerda et al., 2017).